Where has clinical research on BioFlex been conducted?
Several controlled studies have been conducted since 1996 using the BioFlex Professional System. Two of these involved experimental models of Delayed Onset Muscle Soreness (DOMS) and Rheumatoid Arthritis. The results of both studies showed BioFlex producing significant, positive effects on these disorders. A synopsis of these studies is available. Meditech has embarked on an extensive program of Beta Testing of the BioFlex user protocols.
Several controlled studies have been conducted since 1996 using the BioFlex Professional System. Two of these involved experimental models of Delayed Onset Muscle Soreness (DOMS) and Rheumatoid Arthritis. The results of both studies showed BioFlex producing significant, positive effects on these disorders. A synopsis of these studies is available. Meditech has embarked on an extensive program of Beta Testing of the BioFlex user protocols. In January 1997, two BioFlex Professional Systems were placed in Beta sites, one at the University of Toronto in a teaching hospital and one at the University of Ulster. Several additional research units were utilized in private clinics. Results from these centres have indicated that the benefits derived were positive and dramatic.
Ongoing clinical research of various disease entities is conducted onsite at Meditech’s two rehabilitation centres. Several controlled studies have been performed since 1996 using the BioFlex Professional System; two of these involved experimental models of Delayed Onset Muscle Soreness (DOMS) and Rheumatoid Arthritis. The outcomes of both studies showed BioFlex producing significant and positive results. A synopsis of these studies is available on our website.
Several controlled studies have been conducted since 1996 using the BioFlex Professional System. Two of these involved experimental models of Delayed Onset Muscle Soreness (DOMS) and Rheumatoid Arthritis. The results of both studies showed BioFlex producing significant, positive effects on these disorders. A synopsis of these studies is available. Meditech has embarked on an extensive program of beta testing of the BioFlex user protocols. In January, 1997, two BioFlex Professional Systems were placed in beta sites, one at the University of Toronto in a teaching hospital and one at the University of Ulster. Several additional research units were utilized in private clinics. Results from these centres have indicated that the benefits derived were positive and dramatic.
Ongoing clinical research of various disease entities is conducted onsite at Meditech’s two rehabilitation centres. Several controlled studies have been performed since 1996 using the BioFlex Professional System; two of these involved experimental models of Delayed Onset Muscle Soreness (DOMS) and Rheumatoid Arthritis. The outcomes of both studies showed BioFlex producing significant and positive results. A synopsis of these studies is available on our website. Meditech has also embarked on an extensive program of beta testing of the BioFlex user protocols. In January, 1997, two BioFlex Professional Systems were placed in beta sites, one at the University of Toronto in a teaching hospital and one at the University of Ulster. Additional research is being conducted in private clinics. Results from all centres have indicated that the benefits derived from the BioFlex Systems are both positive and dramatic. Thermal versus Low Intensity Laser Therapy High power or thermal lasers can produce
